This page shows the latest Wyeth news and features for those working in and with pharma, biotech and healthcare.
Prior to that, he had served in various senior roles in positions in transplantation and immunology for Wyeth, Novartis and Roche.
The company was founded in 2012 by former senior executives from Wyeth and Pfizer, Drs.
She went on to lead early development programmes at Novartis, including in checkpoint and PI3K inhibitors, and then leadership roles at Morphotek, Pfizer and Wyeth.
Data reviewed by the committee showed that neratinib – a former Wyeth/Pfizer drug - achieved a 33% reduction in the risk that patients would go onto develop recurrent disease within two years.
Pfizer's next mammoth deal, acquiring Wyeth for $68bn in 2009, briefly revived it, but the joke about a 'PfizerKline' or some such union being next in line never actually played
US government deal covers Wyeth’s failure to pay drug rebates. After years of legal wrangling, Pfizer has finally agreed to pay $785m to settle a lawsuit claiming its Wyeth unit ... Meanwhile, the agreement in principle does not include any admission
More from news
Approximately 0 fully matching, plus 230 partially matching documents found.
users, resulting in its manufacturer, Wyeth, paying billions in damages.
In the 1995 AMP/Wyeth merger, the parties divested one of the two development programmes for rotavirus vaccines to the Korean Green Cross.
The affected pharma companies are MSD, Sanofi, Servier, AstraZeneca, Novo Nordisk, Lilly, Janssen- Cilag, Astellas, Wyeth, Roche and PT Orshonovo.
Pfizer (Wyeth) Takeda / Teva Sun Pharmaceutical. Patent settlement. Infringement of Protonix patent.
Nycomed had originally developed the drug, which it had licensed to Wyeth.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
She has worked on both the agency side, at Cello Health Insights and Research Partnership, and on the pharma side at Wyeth (now Pfizer).
He has over 25 years’ experience in ion channel research and development and has held roles for Wyeth Research and Ionix Pharmaceuticals.
Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals - later acquired by Pfizer - and has held other roles withmanaging director for Edelman UK, said: “We
director. Finke brings 15 years industry experience from the likes of Shire and Wyeth (now part of Pfizer) to the Southampton, UK-based agency, having previously worked on market access challenges
His other roles include senior vice president, global pharma operations for Pierre Fabre and has held numerous senior roles with Wyeth Pharmaceuticals, before it was acquired by Pfizer for $68bn back
More from appointments
Approximately 1 fully matching, plus 31 partially matching documents found.
David has been involved in healthcare marketing, strategy and communications for 35 years, working client-side with GD Searle, Wyeth and Novartis in domestic and international roles before moving into the
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
We are a leading provider of outsourced commercial, medical and recruitment services to UK pharmaceutical, biotech and healthcare companies....